Article
DOJ Announces Controlled Substances Act Scheduling Changes For FDA-Approved Marijuana And State-Licensed Medical Marijuana Products
On April 23, 2026, the U.S. Department of Justice (DOJ), in conjunction with the Drug Enforcement Administration (DEA), announced that pursuant to President Trump's December 18, 2025, Executive Order "Increasing Medical Marijuana and Cannabidiol Research," issuance of a final rule by way of Attorney General order (Order) that immediately placed both U.S. Food and Drug Administration (FDA)-approved products containing marijuana and marijuana products regulated by a state medical marijuana license in Schedule
Arnold & Porter